Anti-Cancer Drug Produced by Iranian Nanotechnology Firm
‘Exir Nano Sina’ company has made the product, called SinaDoxosome, which is a cancer treatment drug composed of liposomal hydrochloride doxorubicin, in which the doxorubicin is inserted into a nanoliposome carriers.
The product is highly effective in destruction of cancer cells, reducing their size, and retarding the tumor growth.
Loading the drug inside the nanoliposomal carrier has led to increasing the permeability and stability of the drug and alleviating the side effects of the drug.
The drug can be used for the systematic treatment of metastatic breast cancer, advanced ovarian cancer, multiple myeloma and AIDS-related Kaposi sarcoma.
In a relevant development earlier this year, Iranian researchers developed a technique using nanoparticles to detect cancer spots using semiconductor quantum dots (QDs).
"Producing quantum dot (QD) superluminescent light emitting diode (SLED) for optical and biological applications" is the title of a project completed by Mehdi Molayee, a professor of Valiasr University in Rafsanjan, in the Southeastern province of Kerman.
Molayee said that the technique has applications such as detecting the location of cancerous tumors in addition to their uses in lasers, sensors and cells.
“In the field of nanomaterials, nanosemiconductors, especially nanosemiconductors of group II-VI, have attracted more attention due to their broad applications,” he said.
He added nanosemiconductors have broad applications in different optical, electronic and biological fields.
Semiconductor quantum dots (QDs) are exciting choice for bioimaging applications, notably in cancer imaging, the Iranian researcher said.
4155/v
